NEW YORK (GenomeWeb) – Adoptees signing up for direct-to-consumer genomic testing services often hope to fill the gaps in their family health history and genetic disease risk profile, but they do not differ from nonadoptees in the way they use the results to improve their health, according to a new study by researchers at Brigham and Women's Hospital and Harvard Medical School.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.